Navigation Links
Tufts announces public launch of the Tufts Institute for Biomedical Partnerships website/HUB
Date:2/7/2011

unity to those of us engaged in the discovery and innovation process," said Ira Herman, Ph.D., Professor and Director of the Program in Cellular and Molecular Physiology, Center for Innovations in Wound Healing Research at Tufts University School of Medicine. "We hope that this new portal will enable us to establish meaningful partnerships focused on delivering novel therapeutics and cutting edge technologies, as well as significantly extend current standards of care and clinical practice, locally and globally."

In his recent review of the website/HUB, David Damassa, Ph.D., Dean, Information Technology, Tufts University School of Medicine, commented, "The recently-published Institute for Biopharmaceutical Partnerships website, with its innovative Global Pharma Strategy & Project Development HUB, is a wonderful new resource benefitting both the global pharmaceutical industry and Tufts University. The design of the site and its theme areas of "Discover | Collaborate | Innovate" truly capture the unique culture of Tufts University Particularly compelling are the advanced search features of the HUB and its ability to create individual profiles so that use can be proactively connected with research and people of interest. The new site will undoubtedly raise industry knowledge and awareness of Tufts' established expertise and ability to form strategic alliances with industry, resulting in the development of important new drugs and technologies."

The Institute website/HUB introduces the pharma industry to a range of thematic areas of drug discovery and development expertise:

  • Innovative Therapies (Cancer, Infectious Disease, Cardiometabolic and Pulmonary Disorders, Neurological and Psychiatric Disorders),

  • Technology Platforms (Biomaterials and Biological scaffolding, Genetics, Genomics and Cell Function, Translational and Clinical Pharmacology, Functional Tissue Engineering, Functional Proteomic Screens)

  • Dis
    '/>"/>

Contact: Christine Fennelly
617-636-3707
Tufts University, Health Sciences
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Tufts University Prof. Maria Flytzani-Stephanopoulos named as AAAS Fellow
2. Tufts University professor receives IADR Pharmacology/Therapeutics/Toxicology Award
3. Tufts students host Earth Day with groundbreaking ceremony for solar house
4. Tufts wins NCRR grant for Collaborative Cluster in Genome Structure and Developmental Patterning
5. Tufts graduate students win $10,000 prizes
6. Tufts University chemist earns prestigious award for promising research on drug development
7. Jackson Laboratory and Tufts University announce new Ph.D. track in mammalian genetics
8. NIAID announces 25 new awards to develop radiation countermeasures
9. Aware Announces Q3 2008 Earnings Conference Call
10. Governor Doyle announces historic genomic research collaboration
11. BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 18, 2014   LaunchKey , the first decentralized ... and Internet of Things era, today announced the close ... round was led by Metamorphic Ventures with participation from ... VegasTechFund, and others.  LaunchKey has raised $4 million to ... its team and bring LaunchKey to market in 2015. ...
(Date:12/17/2014)... 16, 2014 Valencell, a leader in performance ... technology to industry leaders such as Intel, Jabra, Atlas, ... biometric wearable products. These products will be showcased at ... Las Vegas . "Our partners ... and robust – with the clinical data to back ...
(Date:12/11/2014)... 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition ... Region 2015-2019"  report to their offering. ... is advances in technology. With continuous advances in ... to the latest standard that meets the needs ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... , The bottled water, soda pop, or micro brew-beer that ... cities contains a natural chemical imprint related to geographic location. ... imprint in your hair that could be used to track ... believed to be the first concerted effort to describe the ...
... looking for new antibiotics: A new research published in the ... ( http://www.fasebj.org ) explains for the first time how honey ... protein that they add to the honey, called defensin-1, which ... infections and to develop new drugs that could combat antibiotic-resistant ...
... WEST LAFAYETTE, Ind. - Fast-food restaurants can supersize French ... to supersize a type of apple. Peter Hirst, a ... in some Gala apple trees causes some apples to grow ... reported in the current issue of the Journal of ...
Cached Biology News:Beverages leave 'geographic signatures' that can track people's movements 2Honey as an antibiotic: Scientists identify a secret ingredient in honey that kills bacteria 2Apples grow larger when cells don't divide, study shows 2
(Date:12/19/2014)... Lawrence, MA (PRWEB) December 19, 2014 ... flow MRLAFMQ test for the Detection of Aflatoxin M1 ... test to receive independent third party validation. The peer ... Science Unit of the Institute for Agricultural and Fisheries ... Francis Group. , Aflatoxin B1, the most toxic ...
(Date:12/19/2014)... , Dec. 19, 2014  Roche (SIX: RO, ... Bina Technologies, Inc. (Bina), a privately held company ... , USA. Bina provides a big data platform ... sequencing (NGS) data. Bina,s proprietary on-market Genomic Management ... academic researchers to perform fast and scalable analyses ...
(Date:12/19/2014)... 19, 2014 Research and Markets ... the "Technology Innovations in Smart Fabrics (Technical ... http://photos.prnewswire.com/prnh/20130307/600769 The ... offers a detailed assessment on technological advancements and ... 1. The Smart Fabrics market ...
(Date:12/19/2014)... LayerBio is an MIT spin-off developing novel drug ... Eye Institute (NEI) at the National Institutes of Health ... to develop a drug-eluting intraocular lens (IOL) for cataract ... vision loss in people over age 40 and the ... Mandell, LayerBio’s Founder and CEO, "There is a critical ...
Breaking Biology Technology:Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Roche acquires Bina Technologies and enters the genomic informatics market 2Roche acquires Bina Technologies and enters the genomic informatics market 3Technology Innovations in Smart Fabrics (Technical Insights) 2LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2
... June 2, 2011 Morphotek®, Inc., a subsidiary of ... multi-center, phase II study of MORAb-004 for the treatment ... potentially first-in-class monoclonal antibody that specifically binds to endosialin/tumor ... its safety and therapeutic activity at two dosages. ...
... Calif., June 2, 2011 Life Technologies Corporation ... performed in cooperation with the University Hospital Muenster, Germany, on ... bacterium at the root of the deadly outbreak in Germany ... strains. The data obtained from the DNA ...
... electrodes have been coated with a drug-loaded polymer in ... a number of neurological symptoms, such as those associated ... In a study published today, 2 June 2011, ... researchers have developed a novel technology to precisely modulate ...
Cached Biology Technology:Morphotek®, Inc. Announces Initiation of MORAb-004 Phase II Study in Melanoma 2Morphotek®, Inc. Announces Initiation of MORAb-004 Phase II Study in Melanoma 3DNA Sequencing Data Reveals New Hybrid E. coli Strain is Cause of German Outbreak 2DNA Sequencing Data Reveals New Hybrid E. coli Strain is Cause of German Outbreak 3DNA Sequencing Data Reveals New Hybrid E. coli Strain is Cause of German Outbreak 4New technology could inspire brain implant for detecting and treating seizures 2
This antibody detects an ~25 kDa band, corresponding to the expected molecular mass of Rab3A, on immunoblots. The antibody specificity is confirmed in peptide inhibition immunoblotting studies....
... antibody reactive against the complex IV assembly factor ... growing cultured cells. SURF1 is an important assembly ... to participate in the folding of subunit II ... of SURF1, particularly ones that result in an ...
100 g monoclonal antibody which can immunocapture ~10 g of Complex IV from heart mitochondria. Also included are 2 mg of bovine heart mitochondria for control immunocapture....
Rabbit polyclonal to GPR56 ( Abpromise for all tested applications). entrezGeneID: 9289 SwissProtID: Q9Y653...
Biology Products: